You can:
Name | Glucagon-like peptide 2 receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GLP2R |
Synonym | GLP-2R GLP-2-R GLP-2 receptor |
Disease | Diarrhea Gastrointestinal disease Short bowel syndrome Osteoporosis Inflammatory bowel disease |
Length | 553 |
Amino acid sequence | MKLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRPFLTLVLLVSIKQVTGSLLEETTRKWAQYKQACLRDLLKEPSGIFCNGTFDQYVCWPHSSPGNVSVPCPSYLPWWSEESSGRAYRHCLAQGTWQTIENATDIWQDDSECSENHSFKQNVDRYALLSTLQLMYTVGYSFSLISLFLALTLLLFLRKLHCTRNYIHMNLFASFILRTLAVLVKDVVFYNSYSKRPDNENGWMSYLSEMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRYLLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTVNFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSFITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVRFLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLLHLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI |
UniProt | O95838 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | T34843 |
ChEMBL | CHEMBL5844 |
IUPHAR | N/A |
DrugBank | N/A |
Name | CHEMBL3824079 |
---|---|
Molecular formula | C173H259N43O52S |
IUPAC name | (4S)-5-[[1-[[(2R)-1-[[(2S,3R)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-5-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(2S,3S)-1-[[(2S,3R)-1-[[(2S)-1-amino-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-thiophen-2-ylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-5-oxopentanoic acid |
Molecular weight | 3805.28 |
Hydrogen bond acceptor | 57 |
Hydrogen bond donor | 53 |
XlogP | -9.2 |
Synonyms | BDBM50183660 |
Inchi Key | PSFPHQQRFHUIAL-KLVGAFGESA-N |
Inchi ID | InChI=1S/C173H259N43O52S/c1-21-26-50-104(192-149(245)108(55-57-129(226)227)193-158(254)120(73-132(232)233)206-165(261)124(81-218)209-155(251)114(65-96-44-32-28-33-45-96)201-164(260)123(80-217)190-128(225)79-185-146(242)119(72-131(230)231)189-127(224)78-184-145(241)102(175)68-99-77-181-82-186-99)147(243)203-117(69-100-48-41-60-269-100)163(259)215-141(94(20)221)172(268)213-137(88(14)24-4)168(264)207-111(62-84(8)9)153(249)205-122(75-134(236)237)160(256)199-113(64-95-42-30-27-31-43-95)154(250)197-110(61-83(6)7)152(248)188-90(16)143(239)187-91(17)144(240)191-106(53-40-59-182-173(179)180)148(244)204-121(74-133(234)235)159(255)200-115(66-97-46-34-29-35-47-97)162(258)212-136(87(13)23-3)167(263)208-118(70-126(177)223)157(253)202-116(67-98-76-183-103-51-37-36-49-101(98)103)156(252)198-112(63-85(10)11)161(257)211-135(86(12)22-2)166(262)195-107(54-56-125(176)222)151(247)214-139(92(18)219)170(266)194-105(52-38-39-58-174)150(246)210-138(89(15)25-5)169(265)216-140(93(19)220)171(267)196-109(142(178)238)71-130(228)229/h27-37,41-49,51,60,76-77,82-94,102,104-124,135-141,183,217-221H,21-26,38-40,50,52-59,61-75,78-81,174-175H2,1-20H3,(H2,176,222)(H2,177,223)(H2,178,238)(H,181,186)(H,184,241)(H,185,242)(H,187,239)(H,188,248)(H,189,224)(H,190,225)(H,191,240)(H,192,245)(H,193,254)(H,194,266)(H,195,262)(H,196,267)(H,197,250)(H,198,252)(H,199,256)(H,200,255)(H,201,260)(H,202,253)(H,203,243)(H,204,244)(H,205,249)(H,206,261)(H,207,264)(H,208,263)(H,209,251)(H,210,246)(H,211,257)(H,212,258)(H,213,268)(H,214,247)(H,215,259)(H,216,265)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H4,179,180,182)/t86-,87-,88-,89-,90-,91-,92+,93+,94+,102-,104?,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117+,118-,119-,120-,121-,122-,123-,124-,135-,136-,137-,138-,139-,140-,141-/m0/s1 |
PubChem CID | 127049891 |
ChEMBL | CHEMBL3824079 |
IUPHAR | N/A |
BindingDB | 50183660 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 0.07 nM | PMID26986178 | BindingDB |
EC50 | 0.07 nM | PMID26986178 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417